After a computer scientist’s mom got breast cancer, he started a company using AI to find biomarkers in biopsy images and give personalized guidance.
Imagene's digitized biopsy image AI diagnostic technology delivers real-time molecular analysis, increasing the level of accuracy and reducing the time required for results, from several weeks to just two minutes.
Imagene's proprietary deep learning algorithms reduce the time required for biomarkers detection from several weeks to two minutes – allowing more cancer.